| Dr Asha Stephen, PHD | |
|
2248 9th St, Springfield, OR 97477-2392 | |
| (541) 838-0833 | |
| Not Available |
| Full Name | Dr Asha Stephen |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Counseling |
| Location | 2248 9th St, Springfield, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710370101 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC1900X | Psychologist - Counseling | 2219 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Asha Stephen, PHD 2248 9th St, Springfield, OR 97477-2392 Ph: (541) 838-0833 | Dr Asha Stephen, PHD 2248 9th St, Springfield, OR 97477-2392 Ph: (541) 838-0833 |
News Archive
A study that compared the benefits and harms of the frequency of screening mammography to age, breast density and postmenopausal use of hormone therapy (HT) suggests that woman ages 50 to 74 years who undergo biennial screenings have a similar risk of advanced-stage disease and a lower cumulative risk of false-positive results than those who get mammograms annually, according to a report published Online First by JAMA Internal Medicine, a JAMA Network publication.
TearScience, a privately-held medical device company, today announced the completion of $44.5 million of Series C funding from new investors Essex Woodlands Health Ventures, Investor Growth Capital and General Catalyst. The company's existing investors, De Novo Ventures, Spray Ventures and Quaker Bio Ventures completed the round. The funding will allow TearScience to commercialize its devices designed for use by eye care professionals to diagnose and treat the most common form of chronic dry eye disease.
Dyax Corp. today announced financial results for the first quarter ended March 31, 2013. The Company will host a webcast and conference call at 5:00 p.m. (ET) today to review financial results and updates regarding its key value drivers - the KALBITOR® (ecallantide) business, the broader angioedema portfolio and the Licensing and Funded Research Program (LFRP).
New policy adopted today by the American Medical Association (AMA) recommends that electronic cigarettes (e-cigarettes) be classified as drug delivery devices, subject to the same FDA regulations as all other drug delivery devices. Additional policy adopted supports prohibiting the sale of e-cigarettes that are not FDA approved.
› Verified 2 days ago
Dr. Helen M Coble, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3995 Marcola Rd, Springfield, OR 97477 Phone: 541-726-1465 Fax: 541-726-5085 | |
Mr. Daniel Patrick Farley, M.A. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3995 Marcola Rd, Springfield, OR 97477 Phone: 541-726-1465 Fax: 541-726-5085 | |
Dr. Frances Everett, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3995 Marcola Rd, Springfield, OR 97477 Phone: 541-726-1465 Fax: 541-726-5085 | |
Terry Stimac, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 175 W B St, Building D, Springfield, OR 97477 Phone: 541-744-0828 Fax: 541-744-1652 | |
Dr. Cady Victoria Kintner, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1192 Island St, Springfield, OR 97477 Phone: 650-387-3541 | |
Elizabeth Anne Dominguez, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 2073 Olympic St, Springfield, OR 97477 Phone: 541-682-3550 |